Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VZV vaccination immunity study in lung transplant candidates
NL-OMON43319Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- May 2016
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of zoster vaccine, live in herpes zoster (HZ) and Varicella zoster infection (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Change in cellular immunity to varicella-zoster virus. Started May 2016; status: active, not recruiting.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)Varicella zoster infection
Beyond the preview
Go deeper on NL-OMON43319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43319.